Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ellen Cai"'
Autor:
Basile Tessier‐Cloutier, Jasleen K Grewal, Martin R Jones, Erin Pleasance, Yaoqing Shen, Ellen Cai, Chris Dunham, Lynn Hoang, Basil Horst, David G Huntsman, Diana Ionescu, Anthony N Karnezis, Anna F Lee, Cheng Han Lee, Tae Hoon Lee, David DW Twa, Andrew J Mungall, Karen Mungall, Julia R Naso, Tony Ng, David F Schaeffer, Brandon S Sheffield, Brian Skinnider, Tyler Smith, Laura Williamson, Ellia Zhong, Dean A Regier, Janessa Laskin, Marco A Marra, C Blake Gilks, Steven JM Jones, Stephen Yip
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 4, Pp 395-407 (2022)
Abstract In this study, we evaluate the impact of whole genome and transcriptome analysis (WGTA) on predictive molecular profiling and histologic diagnosis in a cohort of advanced malignancies. WGTA was used to generate reports including molecular al
Externí odkaz:
https://doaj.org/article/a901dba17e554a43930f20607375541d
Off-label use of common predictive biomarkers in gastrointestinal malignancies: a critical appraisal
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-8 (2019)
Abstract The use of immunohistochemistry (IHC) as a companion diagnostic is an increasingly important part of the case workup by pathologists and is often central to clinical decision making. New predictive molecular markers are constantly sought for
Externí odkaz:
https://doaj.org/article/8e529d3066384af5830bd4632e9e0d74
Autor:
Alisa Abozina, Steve E. Kalloger, Ellen Cai, Tyler Hickey, Fatameh Derakhshan, Nadia S Gale, Ariel Liu, Deidre Ongaro, David F. Schaeffer, Robert Wolber
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 28:422-427
The utility of prognostic and predictive immunohistochemistry biomarkers in the context of cancer is plagued by inconsistent interpretation of results which can lead to poor rates of adoption or inappropriate use of novel therapeutic strategies. To m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::552bae25ab013f05bf571510d2335674
https://doi.org/10.1097/pai.0000000000000784
https://doi.org/10.1097/pai.0000000000000784
Autor:
Laurie H. Sehn, Joseph M. Connors, Ellen Cai, Brandon S. Sheffield, Jan P. Dutz, Kerry J. Savage, Jonathan M. Loree, Lois E. Shepherd, Diego Villa
Publikováno v:
Leukemia & Lymphoma. 58:711-714
Lenalidomide is a synthetic derivative of thalidomide that acts as an immunomodulatory drug (iMiD) and is a treatment option for myelodysplastic syndrome and multiple myeloma, with a developing rol...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a06a31fc462414d39b87bc5a25cf8e51
https://doi.org/10.1080/10428194.2016.1204657
https://doi.org/10.1080/10428194.2016.1204657